Global BCG Vaccine for Tuberculosis (TB) Market Growth 2023-2029

Global BCG Vaccine for Tuberculosis (TB) Market Growth 2023-2029

BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.

LPI (LP Information)' newest research report, the “BCG Vaccine for Tuberculosis (TB) Industry Forecast” looks at past sales and reviews total world BCG Vaccine for Tuberculosis (TB) sales in 2022, providing a comprehensive analysis by region and market sector of projected BCG Vaccine for Tuberculosis (TB) sales for 2023 through 2029. With BCG Vaccine for Tuberculosis (TB) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine for Tuberculosis (TB) industry.

This Insight Report provides a comprehensive analysis of the global BCG Vaccine for Tuberculosis (TB) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine for Tuberculosis (TB) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global BCG Vaccine for Tuberculosis (TB) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine for Tuberculosis (TB) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine for Tuberculosis (TB).

The global BCG Vaccine for Tuberculosis (TB) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for BCG Vaccine for Tuberculosis (TB) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for BCG Vaccine for Tuberculosis (TB) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for BCG Vaccine for Tuberculosis (TB) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key BCG Vaccine for Tuberculosis (TB) players cover Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Tuberculosis (TB) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Immune Type
Therapy Type

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC

Key Questions Addressed in this Report

What is the 10-year outlook for the global BCG Vaccine for Tuberculosis (TB) market?

What factors are driving BCG Vaccine for Tuberculosis (TB) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do BCG Vaccine for Tuberculosis (TB) market opportunities vary by end market size?

How does BCG Vaccine for Tuberculosis (TB) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.